Galectin Therapeutics
GALT
GALT
78 hedge funds and large institutions have $28.8M invested in Galectin Therapeutics in 2019 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 10 closing their positions.
Holders
78
Holders Change
-2
Holders Change %
-2.5%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
25
Reduced
10
Closed
10
Calls
$453K
Puts
$865K
Net Calls
-$412K
Net Calls Change
+$96K
Top Buyers
1 |
1
BlackRock
New York
|
$7.39M |
2 |
2
State Street
Boston,
Massachusetts
|
$1.92M |
3 |
3
Morgan Stanley
New York
|
$468K |
4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$1.56M |
5 |
VF
5
Virtu Financial
New York
|
$157K |